NICE draft advice backs further treatment option for heart failure patients

NICE has issued final draft guidance recommending empagliflozin as an option for adults with symptomatic chronic heart failure with preserved or mildly reduced ejection fraction.

by Chloe Harman

Sign in to continue

Sign In

Trouble signing in?

Reset password: Click here

Need help? Email us

Register

FREE

  • Limited free articles a month 
  • Free email bulletins

Register Now Register Now

Take a 30-day trial

  • Join MIMS now and pay nothing for the first 30 days
  • Join GPOnline now and pay nothing for the first 30 days

Sign Up Sign Up